Patents by Inventor Dennis Ballinger
Dennis Ballinger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20210334957Abstract: Disclosed herein are methods and systems for detection and discrimination of optical signals from a densely packed substrate. These have broad applications for biomolecule detection near or below the diffraction limit of optical systems, including in improving the efficiency and accuracy of polynucleotide sequencing applications.Type: ApplicationFiled: March 17, 2021Publication date: October 28, 2021Inventors: Dennis BALLINGER, Norman BURNS, Manohar FURTADO, Niandong LIU, Windsor OWENS, Bryan STAKER
-
Publication number: 20200040402Abstract: Correlations between polymorphisms and breast cancer are provided. Methods of diagnosing, prognosing, and treating breast cancer are provided. Systems and kits for diagnosis, prognosis and treatment of breast cancer are provided. Methods of identifying breast cancer modulators are also described.Type: ApplicationFiled: July 17, 2019Publication date: February 6, 2020Applicant: Cambridge Enterprise LimitedInventors: David Cox, Dennis Ballinger, Bruce Ponder, Doug Easton
-
Patent number: 10407738Abstract: Correlations between polymorphisms and breast cancer are provided. Methods of diagnosing, prognosing, and treating breast cancer are provided. Systems and kits for diagnosis, prognosis and treatment of breast cancer are provided. Methods of identifying breast cancer modulators are also described.Type: GrantFiled: June 7, 2017Date of Patent: September 10, 2019Assignee: Cambridge Enterprise LimitedInventors: David Cox, Dennis Ballinger, Bruce Ponder, Doug Easton
-
Publication number: 20170275707Abstract: Correlations between polymorphisms and breast cancer are provided. Methods of diagnosing, prognosing, and treating breast cancer are provided. Systems and kits for diagnosis, prognosis and treatment of breast cancer are provided. Methods of identifying breast cancer modulators are also described.Type: ApplicationFiled: June 7, 2017Publication date: September 28, 2017Inventors: David Cox, Dennis Ballinger, Bruce Ponder, Doug Easton
-
Patent number: 9702011Abstract: Correlations between polymorphisms and breast cancer are provided. Methods of diagnosing, prognosing, and treating breast cancer are provided. Systems and kits for diagnosis, prognosis and treatment of breast cancer are provided. Methods of identifying breast cancer modulators are also described.Type: GrantFiled: June 12, 2015Date of Patent: July 11, 2017Assignee: Cambridge Enterprise LimitedInventors: David Cox, Dennis Ballinger, Bruce Ponder, Doug Easton
-
Publication number: 20150354010Abstract: Correlations between polymorphisms and breast cancer are provided. Methods of diagnosing, prognosing, and treating breast cancer are provided. Systems and kits for diagnosis, prognosis and treatment of breast cancer are provided. Methods of identifying breast cancer modulators are also described.Type: ApplicationFiled: June 12, 2015Publication date: December 10, 2015Applicants: Perlegen Sciences, Inc., University of CambridgeInventors: David Cox, Dennis Ballinger, Bruce Ponder, Doug Easton
-
Patent number: 9068229Abstract: Correlations between polymorphisms and breast cancer are provided. Methods of diagnosing, prognosing, and treating breast cancer are provided. Systems and kits for diagnosis, prognosis and treatment of breast cancer are provided. Methods of identifying breast cancer modulators are also described.Type: GrantFiled: February 13, 2009Date of Patent: June 30, 2015Assignee: Cambridge Enterprise LimitedInventors: David Cox, Dennis Ballinger, Bruce Ponder, Doug Easton
-
Patent number: 9051617Abstract: Correlations between polymorphisms and breast cancer are provided. Methods of diagnosing, prognosing, and treating breast cancer are provided. Systems and kits for diagnosis, prognosis and treatment of breast cancer are provided. Methods of identifying breast cancer modulators are also described.Type: GrantFiled: September 24, 2010Date of Patent: June 9, 2015Assignee: Cambridge Enterprise LimitedInventors: David Cox, Dennis Ballinger, Bruce Ponder, Doug Easton
-
Publication number: 20130296173Abstract: The present invention is directed to compositions and methods for improving the discordance rate and mapping yield in nucleic acid sequencing reactions.Type: ApplicationFiled: April 22, 2013Publication date: November 7, 2013Inventors: Matthew Callow, Linsu Chen, Dennis Ballinger
-
Patent number: 8080371Abstract: Correlations between polymorphisms and addiction are provided. Methods of diagnosing, prognosing, and treating addiction are provided. Systems and kits for diagnosis, prognosis and treatment of addiction are provided. Methods of identifying addiction modulators are also described.Type: GrantFiled: March 1, 2007Date of Patent: December 20, 2011Assignee: The Washington UniversityInventors: Dennis Ballinger, Karel Konvicka, Laura Jean Bierut, John Rice, Frank Scott Saccone, Anthony L. Hinrichs, Alison M. Goate, Jen Wang
-
Publication number: 20110015092Abstract: Correlations between polymorphisms and breast cancer are provided. Methods of diagnosing, prognosing, and treating breast cancer are provided. Systems and kits for diagnosis, prognosis and treatment of breast cancer are provided. Methods of identifying breast cancer modulators are also described.Type: ApplicationFiled: September 24, 2010Publication date: January 20, 2011Inventors: DAVID COX, DENNIS BALLINGER, BRUCE PONDER, DOUG EASTON
-
Publication number: 20090239763Abstract: Correlations between polymorphisms and breast cancer are provided. Methods of diagnosing, prognosing, and treating breast cancer are provided. Systems and kits for diagnosis, prognosis and treatment of breast cancer are provided. Methods of identifying breast cancer modulators are also described.Type: ApplicationFiled: February 13, 2009Publication date: September 24, 2009Applicants: PERLEGEN SCIENCES, INC., UNIVERSITY OF CAMBRIDGEInventors: David Cox, Dennis Ballinger, Bruce Ponder, Doug Easton
-
Publication number: 20090239226Abstract: Correlations between polymorphisms and breast cancer are provided. Methods of diagnosing, prognosing, and treating breast cancer are provided. Systems and kits for diagnosis, prognosis and treatment of breast cancer are provided. Methods of identifying breast cancer modulators are also described.Type: ApplicationFiled: February 13, 2009Publication date: September 24, 2009Applicants: PERLEGEN SCIENCES, INC., UNIVERSITY OF CAMBRIDGEInventors: David Cox, Dennis Ballinger, Bruce Ponder, Doug Easton
-
Publication number: 20090208962Abstract: Correlations between polymorphisms and breast cancer are provided. Methods of diagnosing, prognosing, and treating breast cancer are provided. Systems and kits for diagnosis, prognosis and treatment of breast cancer are provided. Methods of identifying breast cancer modulators are also described.Type: ApplicationFiled: February 13, 2009Publication date: August 20, 2009Applicants: PERLEGEN SCIENCES, INC., UNIVERSITY OF CAMBRIDGEInventors: DAVID COX, DENNIS BALLINGER, BRUCE PONDER, DOUG EASTON
-
Publication number: 20090124514Abstract: Multiple unique selection probes are provided in a single medium. Each selection probe has a sequence that is complementary to a unique target sequence that may be present in a sample under consideration. For example, each selection probe may be complementary to a sequence that includes one of the SNPs used to genotype an organism. Single-stranded selection probes anneal or hybridize with sample sequences having the unique target sequences specified by the selection probe sequences. Sequences from the sample that do not anneal or hybridize with the selection probes are separated from the bound sequences by an appropriate technique. The bound sequences can then be freed to provide a mixture of isolated target sequences, which can be used as needed for the application at hand.Type: ApplicationFiled: October 24, 2008Publication date: May 14, 2009Applicant: PERLEGEN SCIENCES, INC.Inventors: Glenn Fu, Laura Stuve, Julie Montgomery, John Sheehan, Charit Pethiyagoda, Amy Ollmann, Naiping Shen, Michael Kennemer, Andrew B. Sparks, Dennis Ballinger
-
Publication number: 20080050393Abstract: The present invention provides novel nucleic acids, novel polypeptide sequences encoded by these nucleic acids and uses thereof.Type: ApplicationFiled: November 22, 2002Publication date: February 28, 2008Inventors: Y. Tom Tang, Vinod Asundi, Dennis Ballinger, Ivan Labat, Dena Leshkowitz, Jin Liu, Deborah Loeb, Julia R. Montgomery, Ann M. Pace, James P. Sheridan, Radoje T. Drmanac
-
Publication number: 20070258898Abstract: Correlations between polymorphisms and addiction are provided. Methods of diagnosing, prognosing, and treating addiction are provided. Systems and kits for diagnosis, prognosis and treatment of addiction are provided. Methods of identifying addiction modulators are also described.Type: ApplicationFiled: March 1, 2007Publication date: November 8, 2007Inventors: Dennis Ballinger, Karel Konvicka, Laura Bierut, John Rice, Frank Saccone, Anthony Hinrichs, Alison Goate, Jen Wang
-
Publication number: 20070166738Abstract: Correlations between polymorphisms and breast cancer are provided. Methods of diagnosing, prognosing, and treating breast cancer are provided. Systems and kits for diagnosis, prognosis and treatment of breast cancer are provided. Methods of identifying breast cancer modulators are also described.Type: ApplicationFiled: November 29, 2006Publication date: July 19, 2007Applicants: Perlegen Sciences, Inc., University of CambridgeInventors: David Cox, Dennis Ballinger, Bruce Ponder, Doug Easton
-
Publication number: 20070092889Abstract: Compositions and methods for use in the therapeutic and preventative treatment, study, diagnosis and prognosis of PD-related disease are disclosed. Also provided are kits and reagents for prognosis and diagnosis of PD-related disease and related conditions.Type: ApplicationFiled: June 2, 2006Publication date: April 26, 2007Applicant: Perlegen Sciences, Inc.Inventors: David Cox, Demetrius Maraganore, Dennis Ballinger, Krishna Pant, Timothy Lesnick
-
Publication number: 20060228728Abstract: A collection of polymorphic sites having resistance or susceptibility to Alzheimer's disease is provided. The sites are useful in methods of diagnosing and treating Alzheimer's disease and related conditions.Type: ApplicationFiled: January 31, 2006Publication date: October 12, 2006Applicant: Perlegen Sciences, Inc.Inventors: David Cox, Dennis Ballinger, Erica Beilharz, Karel Konvicka, Laura Stuve